dermatitis). [10] [11] [12] Children with family history of atopic disease are at high risk to develop the disease. 4, 13, 14 Elevated serum IgE is the hallmark of atopic disease. 15 Initial exposure to allergen (which can occur with priming in utero) leads to sensitization 16 and production of IgE antibodies. 14 During subsequent allergen exposures, allergic inflammation is initiated by cross-linking the allergen with IgE antibodies, followed by mediator release which results in a cutaneous wheal-and-flare reaction, sneezing and runny nose, or wheezing within minutes. 17 For preventive measures, IgE levels are determined as soon as possible, i.e. by analyzing cord blood IgE (CB-IgE).
The role of CB-IgE as a risk factor or predictor of atopic disease has been widely discussed. Croner et al 18 who screened 1,701 newborns found atopic disease developed in 73% infants with high CB-IgE level and positive family history, compared to 3% of infants with low CB-IgE level and no FH. However, other studies couldn't find any association between elevated CBIgE level and atopic manifestations. 19, 20 This study aimed to determine the relationship of atopic disease in children with cord blood IgE (CBIgE) level and family history of atopic disease.
Methods
This was a retrospective cohort study performed from October-December 2004. The subjects were children of 3 years old, whose CB-IgE were already measured at delivery in Kiaracondong Primary Health Care. Data were obtained from a previous report. 21 The inclusion criteria were those whose parents/caregivers agreed to sign written informed consent. Subjects were excluded when they could not be found or moved from Bandung. The initial study consisted of 124 children with equal numbers of positive and negative FH of atopic disease. Total cord blood IgE was measured by Cobas Core Kit to detect the IgE by ELISA.
Determination of atopic disease
Manifestation of atopic disease was determined using the International Study of Asthma and Allergies in Childhood (ISAAC) standardized questionnaire for allergy. 22 Interview was done by the authors and assisted by trained medical staff to collect general data including children's weight and height.
Allergic asthma was diagnosed by recurrent wheezing and/or cough more than three nights in a series. Atopic dermatitis was defined as itchy rash occurring on typical distribution, such as face, neck, flexural and extensor area, and buttocks. Allergic rhinitis /rhino conjunctivitis defined as a nasal discharge, or attacks of sneezing and itching eyes without respiratory infection.
Statistical analysis
Data were analyzed with SPSS version 10.0. Descriptive statistics, including mean and range were calculated for subjects' characteristics. The differentiation of CBIgE levels and FH between the atopic and non atopic children were analyzed by comparative statistics (MannWhitney and chi square test), and considered as significant if P<0.05. Prediction on the incidence of atopic disease was calculated by determining the cut off point of CB-IgE and logistic regression analysis.
Ethical approval
This study received approval from the Health Study Ethical Committee, at Faculty of Medicine University of Padjadjaran/Hasan Sadikin General Hospital Bandung. 
Results
Out of 124 subjects, 94 (76%) fulfilled the inclusion criteria. The characteristics of subjects who were included and excluded in this study are presented in Table 1 . The characteristics include sex, family history of atopic disease and CB IgE level. There was no statistical difference between atopic and non atopic children incidence.
Manifestations of atopic disease occurred in 17/ 94 children, as seen in Figure 1 . Atopic dermatitis was the most common symptom (8 children), followed by both atopic dermatitis and allergic rhinitis (5 children), and allergic rhinitis (4 children).
Comparative statistics were used to evaluate the association between family history and atopic manifestations ( Table 2) . Association between mean value of cord blood IgE levels in atopic and non atopic children is presented in Table 3 .
Children with family history of atopic disease showed higher incidence of atopic manifestations (P<0.001).
Mean value of cord blood IgE levels were also significantly higher in children with atopic manifestations than in non atopic children.
Determining the cut off point of cord blood IgE, the accuracy was highest at level 1.4 IU/mL (77.7%), with sensitivity of 88.2%, specificity of 75.3%. This cut off value pointed out the positive predictive value by 44.1% and negative predictive value by 96.7%. Based on this cut off value, CB-IgE were determined high (>1.4 IU/mL) in 34 children, and low (=1.4 IU/ mL) in 60 children. The incidence of atopy was highest in children with high levels of cord blood IgE (15 out of 17 atopic children) compared to 19 out of 77 in non atopic children. Fifteen of 33 children with positive FH and high CB-IgE levels developed atopic disease. None of negative FH and low CB-IgE levels (n=44) developed atopic manifestations. (Figure 2) .
By logistic regression analysis, the highest prediction of atopic disease was found with (+) FH and high CB-IgE (P=45%), Table 4 . The relative risk of children with high CB-IgE level exclusively in positive family history of atopic disease group (n=49) was 3.636 (95% CI 0.943;14.016).
Discussion
Of the 94 children recruited, atopic disease was found in 18%, with atopic dermatitis as the most common manifestation. This was quite high since this study was done on three year old children, when almost all atopic manifestation arise in the natural history of atopic march. 7 If the data was collected when they were younger (i.e at 18 months), atopic manifestation might be less. In fact our study found that some manifested after the age of two. Other studies showed different finding. Croner 18 found 8% children developed obvious or probable atopic disease, predominantly atopic dermatitis and bronchial asthma during the first 18 months of life, while other investigators found incidence of 12.9% and 36.6%. 19, 20 Great variations of the definition of atopy between the different studies could interfere with the results. Our study used ISAAC standardized questionnaire for allergy which had been validated to determine the incidence of atopic manifestation. However, other tests are also useful in confirming the precise diagnosis, such as the skin prick test.
Genetic factors play an important role in the development of atopic disease. Atopic manifestations in children with family history of atopic disease was highly significant in our study (P<0.001).
In children with atopy, there is no doubt that elevated total IgE level has positive association with disease manifestation. An increase in IgE level points out evidence of sensitization which could occur with priming in utero. 8, 14, 16 Cord blood IgE measurements in several studies showed different results. [18] [19] [20] IgE screening in 1,701 newborn infants noted that 70% infants with high cord blood IgE concentration developed obvious or probable atopic disease during the observation period, 18 while others reported otherwise. 19, 20 Many factors might influence the outcome, such as laboratory methods, blood sampling techniques, cut off values and also precise criteria of atopic diagnosis. By using a level of 1.4 IU/ml CB-IgE concentration as cut off value in our study (which was different from other reports), significant differences were noticed. The predictive value was quite poor (44.1%), however measuring CB-IgE at delivery should have significant meaning for identifying risk factor in infants.
Children with positive FH and high CB-IgE levels developed atopic disease more often 18 as found in our study (P=45%).
Expression of Th2-skewed immunity to ubiquitous environmental allergen is the hallmark of the atopic phenotype, in contrasts with the balanced Th1/Th2 pattern in normal individuals. Synthesis of IgE and clinical manifestations depend on the interaction of multiple gene products with environmental allergens. 2 The fetus is known to synthesize IgE from the 11th gestational week. The study by Croner et al 18 did not suggest that IgE could be transmitted across the placental barier. Assuming that sensitization can occur in fetal life, the relative risk for atopic manifestation in children with (+) FH and increased CB-IgE level should be higher than those without. In our study the relative risk was 3.636 (95% CI 0.943;14.016). However, the evidence of fetal specific sensitization to certain allergens was unproven, since the cord blood specific IgE were not measured in this study. Overall, our findings may be useful to plan early prevention 22, 23 
Figure 2. Developed atopic manifestations
Note: * = can not be analyzed FH = family history of atopic disease CB-IgE = cord blood IgE in children who might have atopic disease later. The cut off value of cord blood IgE in this study should be determined further. For appropriate recommendations, further investigation with larger population is necessary. In conclusion CB-IgE level and family history of atopic disease are risk fators for the development of atopic manifestation.
